Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
11 11 2023
Historique:
received: 18 04 2023
medline: 13 11 2023
pubmed: 5 7 2023
entrez: 4 7 2023
Statut: ppublish

Résumé

Gram-negative bacteremia (GN-BSI) can cause significant morbidity and mortality, but the benefit of infectious diseases consultation (IDC) is not well defined. A 24-site observational cohort study of unique hospitalized patients with 4861 GN-BSI episodes demonstrated a 40% decreased risk of 30-day mortality in patients with IDC compared to those without IDC.

Identifiants

pubmed: 37402637
pii: 7218962
doi: 10.1093/cid/ciad383
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1234-1237

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. D. J. L. receives funding from VA HSR&D, Centers for Disease Control and Prevention (CDC) and Merck Investigator Studies Program. A. N. M. reports payment for expert testimony outside of the submitted work; shares of Pfizer pharmaceuticals; membership of Society Healthcare Epidemiology of America (SHEA) Board of Trustees (2020–2022); board membership of Michigan Infectious Diseases Society; consultancy for and grant funding from Michigan Department of Health and Human Services. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Stephanie Shulder (S)

Department of Pharmacy, University of Rochester Medical Center, Rochester, New York, USA.

Pranita D Tamma (PD)

Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Suiyini Fiawoo (S)

Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Kathryn Dzintars (K)

Department of Infectious Diseases, Johns Hopkins University School of Pharmacy, Baltimore, Maryland, USA.

Daniel Escobar (D)

Department of Medicine, Division of Infectious Disease, University of California San Francisco, San Francisco, California, USA.

Daniel J Livorsi (DJ)

Division of Infectious Diseases, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Iowa City Veterans Affairs (VA) Health Care System, Iowa City, Iowa, USA.

Anurag N Malani (AN)

Trinity Health Michigan, Section of Infectious Diseases, Ann Arbor, Michigan, USA.

Danica Palacio (D)

Trinity Health Michigan, Section of Infectious Diseases, Ann Arbor, Michigan, USA.

Emily S Spivak (ES)

Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Matty Zimmerman (M)

Department of Infectious Diseases, Johns Hopkins University School of Pharmacy, Baltimore, Maryland, USA.

Jacqueline T Bork (JT)

Department of Medicine, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH